Christopher Parrish
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Virus-based gene therapy research
Papers in
- Hematology 39
- Multiple Myeloma Research and Treatments 36
- Hematopoietic Stem Cell Transplantation 3
- Genetics 7
- Virus-based gene therapy research 7
- Chronic Lymphocytic Leukemia Research 1
- Co-authors
- Gordon C Cook (27 shared papers)Alan A. Melcher (8 shared papers)Gina B. Scott (9 shared papers)Matt C. Coffey (6 shared papers)Elizabeth J. Ilett (5 shared papers)Hardev Pandha (4 shared papers)Kwee Yong (7 shared papers)Jim Cavet (6 shared papers)
- Journals
- Blood (12 papers)British Journal of Haematology (7 papers)Molecular Therapy (4 papers)The Lancet Haematology (3 papers)BMJ Open (2 papers)
- Partner nations
- United KingdomUnited StatesChina
In The Last Decade
Christopher Parrish
48 papers receiving 892 citations
Peers
Comparison fields: 5 of 40
- Hematology 508
- Genetics 204
- Oncology 118
- Immunology 87
- Genetics 28
Countries citing papers authored by Christopher Parrish
This map shows the geographic impact of Christopher Parrish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Parrish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Parrish more than expected).
Fields of papers citing papers by Christopher Parrish
This network shows the impact of papers produced by Christopher Parrish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Parrish. The network helps show where Christopher Parrish may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Parrish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 164 | |
| 2 | 2014 | 128 | |
| 3 | 2016 | 119 | |
| 4 | 2012 | 70 | |
| 5 | 2015 | 37 | |
| 6 | 2019 | 32 | |
| 7 | 2022 | 29 | |
| 8 | 2009 | 28 | |
| 9 | 2012 | 23 | |
| 10 | 2015 | 23 | |
| 11 | 2019 | 20 | |
| 12 | 2021 | 17 | |
| 13 | 2019 | 16 | |
| 14 | 2021 | 15 | |
| 15 | 2011 | 13 | |
| 16 | 2014 | 13 | |
| 17 | 2022 | 13 | |
| 18 | 2022 | 13 | |
| 19 | 2022 | 12 | |
| 20 | 2016 | 10 |
About Christopher Parrish
Christopher Parrish is a scholar working on Hematology, Genetics, Immunology, Oncology and Genetics, having authored 53 papers that have together received 907 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (36 papers), Virus-based gene therapy research (7 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Chronic Lymphocytic Leukemia Research (1 paper) and Blood transfusion and management (1 paper). The work is most often cited by research in Hematology (508 citations), Genetics (204 citations), Oncology (118 citations), Immunology (87 citations) and Genetics (28 citations). Christopher Parrish has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Gordon C Cook, Alan A. Melcher, Gina B. Scott, Matt C. Coffey, Elizabeth J. Ilett, Hardev Pandha, Kwee Yong, Jim Cavet, Kevin Joseph Harrington and Richard G. Vile. Their work appears in journals such as Blood, British Journal of Haematology, Molecular Therapy, The Lancet Haematology and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.